Sublingual immunotherapy;Sublinguale immuntherapie

JDDG - Journal of the German Society of Dermatology

Volumn 4, Issue 5, 2006, Pages 428-434

  Heinzerling, Lucie ^a   Worm, Margitta ^a   Bergmann, Karl Christian ^a   Zuberbier, Torsten ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYTOKINE; FC RECEPTOR; GAMMA INTERFERON; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC ASTHMA; ALLERGIC DISEASE; ALLERGIC RHINITIS; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIBODY PRODUCTION; ASTHMA; BURNING SENSATION; DENDRITIC CELL; DESENSITIZATION; DIARRHEA; ECZEMA; EOSINOPHIL; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; INJECTION SITE REACTION; MAST CELL; PINOCYTOSIS; PRURITUS; REGULATORY T LYMPHOCYTE; REVIEW; SUBLINGUAL DRUG ADMINISTRATION; SYMPTOM; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TREATMENT CONTRAINDICATION; URTICARIA;

ADMINISTRATION, SUBLINGUAL; DESENSITIZATION, IMMUNOLOGIC; GERMANY; HUMANS; HYPERSENSITIVITY; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY; INJECTIONS, SUBCUTANEOUS; MOUTH FLOOR; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES;

EID: 33646552412     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2006.05953.x     Document Type: Review

References (12)

1. Durham S, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W, Till SJ, Hamid QA, Nouri-Aria KT. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999; 341: 468-475.
2. Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K, Akdis CA. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003; 33: 1205-1214.
3. Till SJ, Francis JN, Nouri-Aria K, Durham S. Mechanisms of immunotherapy. J Allergy Clin Immunol 2004; 113: 1025-1034.
4. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: Therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998; 102: 558-562.
5. Malling HJ. Is sublingual immunotherapy clinically effective? Curr Opin Allergy Clin Immunol 2002; 2: 523-531.
6. Bousquet J, van Cauwenberge P, editors. Allergic rhinitis and its impact on asthma (ARIA). J Allergy Clin Immunol 2001; 108: S147-334.
7. Wilson DR, Torres Lima M, Durham S. Sublingual immunotherapy for allergic rhinitis (Cochrane Review). In: The Cochrane Library, Issue 2, 2003. Chichester, UK: John Wiley & Sons, Ltd.
8. Abramson MJ, Puy RM, Weiner JM. Allergen immunotherapy for asthma (Cochrane Review). In: The Cochrane Library, Issue 4, 2004. Chichester, UK: John Wiley & Sons, Ltd.
9. Khinchi MS, Poulsen LK, Carat F, Andre C, Hansen AB, Malling HJ. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: A randomized, placebo-controlled, double-blind, double-dummy study. Allergy 2004; 59: 45-53.
10. Lüderitz-Püchel U, Keller-Stanislawski B, Haustein D. Neubewertung des Risikos von Test- und Therapieallergenen. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 2001; 7: 709-718.
11. André C, Vatrinet C, Galvain S, Carat F, Sicard H. Safety of sublingual-swallow immunotherapy in children and adults. Int Arch Allergy Immunol 2000; 121: 229-234.
12. Clavel R, Bousquet J, Andre C. Clinical efficacy of sublingual-swallowing immunotherapy: a double-blind, placebo-controlled trial of standardized five-grass-pollen extract in rhinitis. Allergy 1998; 53: 493-8.